Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…"

Suggestive significant associations in the candidate gene approach. حسب Dai Nogimura (21445649)

الموضوعات:

Global and national estimates of deaths due to <i>Klebsiella pneumoniae</i>-associated lower respiratory infections in 1990 and 2021. حسب Juanjuan Li (399633)

الموضوعات:

The linearly decreasing convergence factor a. حسب Junhao Wei (6816803)

A Comparison of Pediatric Prehospital Opioid Encounters and Social Vulnerability حسب Stephen Sandelich (19991783)

الموضوعات:

Forest plot of the improvement in primary endpoints. حسب Jin-Min Gu (17915039)

الموضوعات:

Definitions of variables. حسب Qi Zhang (28502)

الموضوعات:

Theoretical model diagram. حسب Qi Zhang (28502)

الموضوعات:

PSM and Heckman regression results. حسب Qi Zhang (28502)

الموضوعات:

Regression results from a business risk perspective. حسب Qi Zhang (28502)

الموضوعات:

Other robustness test regression results. حسب Qi Zhang (28502)

الموضوعات:

Baseline regression results. حسب Qi Zhang (28502)

الموضوعات:

Univariate analysis results. حسب Qi Zhang (28502)

الموضوعات:

Regression results for heterogeneity in corporate life cycle. حسب Qi Zhang (28502)

الموضوعات:

Regression results of mechanism analysis. حسب Qi Zhang (28502)

الموضوعات:

Long-term economic consequence test results. حسب Qi Zhang (28502)

الموضوعات:

Descriptive statistical results. حسب Qi Zhang (28502)

الموضوعات:

Financing environment and regional heterogeneity regression results. حسب Qi Zhang (28502)

الموضوعات:

Instrumental variable regression results. حسب Qi Zhang (28502)

الموضوعات:

Unconfined Compressive Strength of Improved Red Clay. حسب Quan Shen (37564)

الموضوعات: